Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Kalaycio

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|February 24, 2004
Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literatureJohn Hill, R Matthew Walsh, Scott McHam, et al.
Leukemia & Lymphoma|September 21, 2011
Pulmonary involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma is a specific pathologic finding independent of inflammatory infiltrationBrian T Hill, Andrew C Weil, Matt Kalaycio, et al.
European Heart Journal|December 28, 2016
Hot stuff: a rare diagnosis of a mitral valve mass confirmed on cardiac fludeoxyglucose positron emission tomographyJames Lewis Gentry, Matt Kalaycio, Samuel Tay Chao, et al.
British Journal of Haematology|October 18, 2013
Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL)Brian T Hill, Paolo Caimi, Tammy Kindwall-Keller, et al.
Blood|September 19, 2014
Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populationsLoren Gragert, Stephanie Fingerson, Mark Albrecht, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Prediction of response and progression in multiple myeloma with serum free light chains assay: corroboration of the serum free light chain response definitionsRami Khoriaty, Mohamad A Hussein, Beth Faiman, et al.
Clinical Transplantation|November 15, 2006
High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplantMatt Kalaycio, Brad Pohlman, Elizabeth Kuczkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemiaMatt Kalaycio, Lisa Rybicki, Brad Pohlman, et al.
American Journal of Hematology|August 30, 2008
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemiaMatt Kalaycio, Anjali Advani, Brad Pohlman, et al.
BMC Cancer|May 23, 2002
Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trialXing-Yue He, Paul Elson, Brad Pohlman, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|February 24, 2004
Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literatureJohn Hill, R Matthew Walsh, Scott McHam, et al.
Leukemia & Lymphoma|September 21, 2011
Pulmonary involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma is a specific pathologic finding independent of inflammatory infiltrationBrian T Hill, Andrew C Weil, Matt Kalaycio, et al.
European Heart Journal|December 28, 2016
Hot stuff: a rare diagnosis of a mitral valve mass confirmed on cardiac fludeoxyglucose positron emission tomographyJames Lewis Gentry, Matt Kalaycio, Samuel Tay Chao, et al.
British Journal of Haematology|October 18, 2013
Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL)Brian T Hill, Paolo Caimi, Tammy Kindwall-Keller, et al.
Blood|September 19, 2014
Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populationsLoren Gragert, Stephanie Fingerson, Mark Albrecht, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Prediction of response and progression in multiple myeloma with serum free light chains assay: corroboration of the serum free light chain response definitionsRami Khoriaty, Mohamad A Hussein, Beth Faiman, et al.
Clinical Transplantation|November 15, 2006
High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplantMatt Kalaycio, Brad Pohlman, Elizabeth Kuczkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemiaMatt Kalaycio, Lisa Rybicki, Brad Pohlman, et al.
American Journal of Hematology|August 30, 2008
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemiaMatt Kalaycio, Anjali Advani, Brad Pohlman, et al.
BMC Cancer|May 23, 2002
Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trialXing-Yue He, Paul Elson, Brad Pohlman, et al.
Pageof 16